Avoid common mistakes on your manuscript.
Publisher Correction: European Journal of Clinical Microbiology & Infectious Diseases
The publisher regrets that the article has been published online on 01 March 2019 with errors in Table 1.
In the originally published Table 1, the percentage of Imipenem-relebactam susceptibility was incorrectly written as 8 0, while correct data is 98.0. Also, in Meropenem row, column MIC50 (mg/L), the incorrect data 4 should be 64.
Subsequently, the revised Table 1 with the corrected data is shown below.
The original article has been corrected.
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1007/s10096-019-03517-y
Rights and permissions
About this article
Cite this article
Galani, I., Souli, M., Nafplioti, K. et al. Correction to: In vitro activity of imipenem-relebactam against non-MBL carbapenemase-producing Klebsiella pneumoniae isolated in Greek hospitals in 2015–2016. Eur J Clin Microbiol Infect Dis 38, 1151–1152 (2019). https://doi.org/10.1007/s10096-019-03553-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-019-03553-8